Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

James Gubbins
James Gubbins
Partner
London +44 20 7067 2065 jgubbins@cov.com Download V-card

James Gubbins is a partner in Covington’s corporate practice, resident in the firm's London office.

Mr. Gubbins has extensive experience in advising on mergers and acquisitions, IPOs and other securities issues, financings and private equity transactions.  His practice covers a range of industries and he has particular experience in the life sciences and technology sectors.  His clients include corporates, private equity funds and investment banks.

Memberships and Affiliations

  • PLC Venture Capital multi-jurisdictional guide, Member of the Editorial Board
  • LMG Life Sciences Europe, Life Sciences Star - Financial & Transactional (United Kingdom) (2014-2015)
  • Chambers UK, Life Sciences: Transactional (2011-2019)
  • Chambers UK, Private Equity: Venture Capital Investment (2015-2019)
  • Chambers UK, Life Sciences (2016-2018)
  • Chambers UK, Private Equity: Buyouts (2012-2014)
  • Chambers Global, Life Sciences (2014)
  • Best Lawyers in United Kingdom, Life Sciences and Venture Capital (2009-2014)
  • Legal 500 UK, Venture Capital (2012-2016)
  • Legal 500 UK, Equity Capital Markets (2015)  
  • Legal 500 UK, Pharmaceuticals & Biotechnology (2013)
  • Legal 500 UK, Flotations, Small and Mid-Cap (2011-2012)
  • Who's Who Legal, Life Sciences (2013-2017)
  • PLC Which Lawyer?, England - Venture Capital, Capital Markets Equity, and Life Sciences - Corporate (2010-2012)